General Information on R&D
I: R&D Team
The team is formed by senior researchers who have rich experience in biological products’ R & D in China. Meanwhile, top scientists in the field from all over the world are invited as consultants to provide technical support and guidance for the establishment and implementation of R&D projects.
II: Vaccine R&D Pilot Platform
The Vaccine R&D Pilot Platform is designed and built in compliance with Chinese GMP 2010. The sterile workshop is about 1000m2, which is available for strain preparation; cell culture; bacterial fermentation; products’ purification; preparations’ formulation; sub-packaging and lyophilizing.
Research and innovation is the vital force of an enterprise. Olymvax adopts the “independent research and cooperating research” as R&D model. Through years’ hard working, Olymvax has formed a stair-like product development type, that is, with a rich products’ follow-up reservation, 2 vaccine products already launched on the market; several products entered Clinical trials and numerous products are pipelined at a stable pace.